Skip to content

New Dimension in Chromatography - Halo® 1.5

LC-MS Separation of Drugs of Abuse and Metabolites on HALO® Penta-HILIC

clinical toxicology testing - lc-ms separation of drugs of abuse and metabolites

Bonded Phase: Penta-HILIC

Market Segment: Clinical/Toxicology

Particle Size: 2.7 µm

Pore Size: 90 Å

Product Segment: SMALL MOLECULE

Separation Mode: HILIC

Download File
Back To Top